Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002378)
Private Donations
- License Information
-
More Information
Article History
Received: 3 April 2025
Accepted: 10 August 2025
First Online: 10 October 2025
Declarations
:
: The present study was approved by the Internal Review Board at Emory University (00002447) and was carried out in accordance with the provisions of the World Medical Association Declaration of Helsinki. Informed consent was obtained for all individuals prior to participation.
: RHS has served on advisory boards for Danone and Synlogic Therapeutics. RHS has also served as PI for research studies funded by BioMarin. MSS received honoraria from Ajinomoto Cambrooke and Relief Therapeutics for presentations at educational events. SN has no competing interests to disclose. The authors confirm independence from the aforementioned entities; the content of the article has not been influenced by the entities.
